Ambys Medicines

About:

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Website: https://www.ambys.com

Twitter/X: ambysmedicines

Top Investors: Alexandria Venture Investments, Takeda, Schroders Capital, Third Rock Ventures, Smilegate Investment

Description:

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.

Total Funding Amount:

$187M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)ambys.com

Founders:

Holger Willenbring, Juan Carlos Izpisua Belmonte, Markus Grompe, Martin Burke

Number of Employees:

51-100

Last Funding Date:

2021-12-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai